WEBINARS A series of live, interactive 2021/22 - PVRI - Pulmonary Vascular ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
PVRI
The research continues. Pulmonary Vascular
Research Institute
WEBINARS
A series of live, interactive
2021/22
Please join us for these exciting new online meetings.
Preliminary PROGRAMME
PVRI
Pulmonary Vascular
Research Institute
“i am pleased to announce a series of
webinars and online meetings that continue
the fantastic work of the PVri for our
global members and young scientists.”
Werner Seeger in the absence of the PVri in-person meetings and symposia, these online
President 2020-2022, webinars will enable us to stay in contact with our worldwide community,
Justus-Liebig University Giessen, but also to explore and discuss important new research.
Germany
Following the success of the DDS 2020 DiGiTal online Drug & Development
Symposium in June 2020, we are excited to launch this series of interactive
live webinars and look forward to active discussion and debate throughout
the year.
During the live webinar sessions, there will be plenty of time set aside for Q&A to encourage active
participation from our audience. All presentations will be available to download after the event.
We encourage you to participate in this exciting new feature and register online.
reGiSTraTion iS Free For PVri PaiD memberS.
PVRI
Pulmonary Vascular
Research Institute
introducing the
Scientific organisers...
We would like to thank our Scientific organising Committee,
Our Scientific Leaders...
under the leadership of Patricia Thistlethwaite and Stephan rosenkranz,
for putting together such an outstanding programme of stimulating
and novel talks.
Many thanks also to all chairs, speakers and abstract presenters for contributing to
this exciting new feature.
Patricia Thistlethwaite Stephen rosenkranz
• University of California, • University of Cologne, Details of the abstract submission process and how to register for the webinars
San Diego, USA Germany will soon be available.
Our Scientific Planning Committee...
Sébastien bonnet allan lawrie Stelios orfanos rogerio Souza rebecca Vanderpool
• Laval University, • University of Sheffield, • University of Athens • University of Sao Paulo, • University of Arizona
Canada UK Medical School, Brazil College of Medicine
Greece - Tuscon, USA
PVRI
Pulmonary Vascular
Research Institute
Webinars
Dates and topics for the webinar series in 2021:
coming up in
Wednesday Wednesday Wednesday Wednesday
27 January 24 February 24 march 28 april
2021 2021 2021 2021
2021
around the globe: Keynote lecture Connection Virtual poster
Global burden session between discussion
of pulmonary CoViD-19 and session 1
hypertension pulmonary
vascular disease
SaVe The DaTeS Wednesday Wednesday Wednesday Wednesday
26 may 23 June 28 July 25 august
2021 2021 2021 2021
Calendar of
novel imaging Joint Symposium Pro-Con The notch
approaches in with the eSC: debate receptors:
pulmonary The pulmonary session 1 multi-regulators
events...
hypertension circulation in the of Pah
patients heart failure development
syndrome
Wednesday Wednesday Wednesday Wednesday
PVri webinars arranged in 2021
29 September 27 october 24 november 15 December
2021 2021 2021 2021
beyond Dna: Joint Symposium machine learning Pro-Con
The unseen with the iShlT: and artificial debate session 2:
Webinars take place on the last Wednesday of each month from genome and end-stage Pah intelligence medical vs surgical
15:00-17:00 GmT, so you can easily schedule these in your calendars. novel omics - how and what approaches for Ph: or interventional
approaches to do we do in From screening to therapy for
Click on each meeting for further information on chairs, speakers and presentation topics. Ph 2021? novel drug targets CTePh
PVRI
Pulmonary Vascular
Research Institute
Webinars
coming up in
Dates and topics for the webinar series in 2022:
2022 Wednesday
26 January
2022
Wednesday
23 February
2022
Wednesday
30 March
2022
Wednesday
27 April
2022
SAVE THE DATES
Vitual poster Bone marrow Aging and The association
discussion modulation of pulmonary between cancer
session 2 pulmonary hypertension: and PH:
vascular An endemic on A tale of two
disease the horizon? diseases
Calendar of
events...
Wednesday
25 May
2022
Paediatric
PH
PVRI webinars arranged in 2022
Webinars take place on the last Wednesday of each month from
15:00-17:00 GMT, so you can easily schedule these in your calendars.
Click on each meeting for further information on chairs, speakers and presentation topics.
Presentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 1
participants after the webinar.
Date // 27 January 2021
NOTE: All times indicated are Greenwich mean Time (GMT)
around the globe:
Global burden of pulmonary hypertension
Presentations:
• The view of the World Heart Federation (WHF)
• Role of WHO/NCDA in promoting global health with a focus on
cardiovascular disease
• Update on the Global Burden of PH Project of the Institute for
Health Metrics and Evaluation (IHME)
• PVRI GoDeep: Perspectives of a global meta-registry
• Best abstract
• Best abstract
back to
calendar
Presentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 2
participants after the webinar.
Date // 24 February 2021
NOTE: All times indicated are Greenwich mean Time (GMT)
Keynote lecture session 2021
Presentations:
• Keynote lecture 1
mHealth and wearables: Is this the dawn of a new age for
cardiovascular medicine?
• Keynote lecture 2
The role of ion channels as multi-purpose regulators in PH
• Best abstract
• Best abstract
• Best abstract
back to
calendar
Presentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 3
participants after the webinar.
Date // 24 march 2021
NOTE: All times indicated are Greenwich mean Time (GMT)
Connection between CoViD-19 and
pulmonary vascular disease
Presentations:
• SARS-1, MERS, SARS-2 and more: Are coronavirus infections an
ubiquitous part of our lives?
• Endothelitis and aberrant angiogenesis: Mechanisms of COVID-19
induced vascular injury
• Venous thromboembolism in COVID-19: Prevalence and clinical picture
• ACE-II receptors: Modulation of PVD in COVID-19?
• Best abstract
• Best abstract
back to
calendar
Presentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 4
participants after the webinar.
Date // 28 april 2021
NOTE: All times indicated are Greenwich mean Time (GMT)
Virtual poster discussion session 1
Virtual poster discussion session 1
Presentations
Presentations:
round 1 baSiC
round 1 baSiC
Poster 1
• Poster 1
• Poster 2 Poster 2
• Poster 3
Poster 3
• Poster 4
• Poster 5 Poster 4
• Poster 6 Poster 5
Poster 6
• round 2 CliniCal
• Poster 1 round 2 CliniCal
• Poster 2
Poster 1
• Poster 3
• Poster 4 Poster 2
• Poster 5 Poster 3
• Poster 6
back to
calendar
Presentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 5
participants after the webinar.
Date // 26 may 2021
NOTE: All times indicated are Greenwich mean Time (GMT)
novel imaging approaches in pulmonary
hypertension patients
Presentations:
• Update from the Fleischner Society Task Force for imaging in pulmonary
hypertension
• Molecular imaging of pulmonary vascular disease using microvascular
endothelial cell ligands
• MRI to assess pulmonary vascular changes and PH progression
• Xenon magnetic resonance imaging signatures of PH
• Synchrotron-based phase contrast micro-CT imaging of pulmonary
vascular disease in human tissue and animal models
back to
calendarPresentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 6
participants after the webinar.
Date // 23 June 2021
NOTE: All times indicated are Greenwich mean Time (GMT)
Joint Symposium with the eSC:
The pulmonary circulation in the heart failure
syndrome
Presentations
• The right ventricle in HFpEF
• Genetic aspects in Group2 PH
• Exercise haemodynamics in heart failure: What can we learn from
invasive CPET?
• Systemic consequences and interorgan cross-talk in heart failure and PH
• Best abstract
• Best abstract
back to
calendarPresentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 7
participants after the webinar.
Date // 28 July 2021
NOTE: All times indicated are Greenwich mean Time (GMT)
Pro-Con debate session 1
Presentations
Topic a:
• role of pulmonary vascular pruning in Pah
• PRO:
A hopeless cause: The pulmonary vasculature is largely gone and
irredeemable in PAH
• CON:
Remnants of lost pulmonary vasculature may be re-engaged in PAH
Topic b:
• Treatment of patients with mild Pah
• PRO:
Patients with mild pulmonary hypertension (mPAP 21-24) should be
treated with PAH approved drugs
• CON:
Patients with mild pulmonary hypertension (mPAP 21-24) should NOT be
treated with PAH approved drugs
back to
calendarPresentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 8
participants after the webinar.
Date // 25 august 2021
NOTE: All times indicated are Greenwich mean Time (GMT)
The notch receptors:
multi-regulators of Pah development
Presentations:
• Role of notch1 in experimental pulmonary hypertension
• Notch-BMPR interactions in endothelium in PAH
• Notch3 is a driver and biomarker for PAH
• Notch3 lineage and pulmonary vasculopathy
• Cardiopulmonary consequences of inhibiting DLL4
back to
calendarPresentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 9
participants after the webinar.
Date // 29 September 2021
NOTE: All times indicated are Greenwich mean Time (GMT)
beyond Dna:
The unseen genome and novel omics approaches
to Ph
Presentations:
• MicroRNAs and IncRNAs in right heart hypertrophy and failure
• LncRNA as biomarkers/therapeutic agents for pulmonary diseases
- prospective view
• Epigenomics in pulmonary vascular remodelling
• CITE-seq: Enabling single cell multi-omic analyses
• Proteomics: From discovery research toward the clinic - novel AI
perspectives?
back to
calendarPresentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 10
participants after the webinar.
Date // 27 october 2021
NOTE: All times indicated are Greenwich mean Time (GMT)
Joint symposium with the iShlT:
end-stage Pah - how and what do we do in 2021?
Presentations:
• When should a PH patient be considered for lung transplant?
• Atrial septum defect creation or mechanical support for end-stage PAH
• Lung and heart-lung transplant in 2021:
How well do PAH patients do?
• The future of artificial lungs
• Timing and extent of ventricular reverse remodelling after lung transplant
for PH
back to
calendarPresentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 11
participants after the webinar.
Date // 24 november 2021
NOTE: All times indicated are Greenwich mean Time (GMT)
machine learning and artificial intelligence
approaches for Ph:
From screening to novel drug targets
Presentations:
• Looking beyond the hype: Applied AI and machine learning in translational
medicine
• Computational network pharmacology in cardiovascular disease:
Leveraging big data
• Drug discovery using artificial intelligence engines: Challenges and
opportunities
• Utilising artificial intelligence to screen and diagnose iPAH
• Best abstract
• Best abstract
back to
calendarPresentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 12
participants after the webinar.
Date // 15 December 2021
NOTE: All times indicated are Greenwich mean Time (GMT)
Pro-Con debate session 2:
medical vs. surgical or interventional therapy
for CTePh
Presentations:
• PRO:
Riociguat should be given to all CTEPH patients, regardless of timing of
PEA/BPA
• CON:
Riociguat should be given only to patients with inoperable or residual
CTEPH after PEA/BPA
• Best abstract
• Best abstract
• Best abstract
• Best abstract
• Best abstract
back to
calendarPresentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 13
participants after the webinar.
Date // 26 January 2022
NOTE: All times indicated are Greenwich mean Time (GMT)
Virtual poster discussion session 2
Presentations:
round 1 baSiC
• Poster 1
• Poster 2
• Poster 3
• Poster 4
• Poster 5
• Poster 6
• round 2 CliniCal
• Poster 1
• Poster 2
• Poster 3
• Poster 4
• Poster 5
• Poster 6
back to
calendarPresentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 14
participants after the webinar.
Date // 23 February 2022
NOTE: All times indicated are Greenwich mean Time (GMT)
bone marrow modulation of pulmonary
vascular disease
Presentations:
• Role of bone marrow in the pathogenesis of PAH
• Role of bone marrow in the right ventricle remodelling
• Reversal of PH by whole bone marrow transplantation in BMPR2
deficient mice
• Bone marrow dependency of cigarette smoke-induced PH versus
emphysema
• Homologous bone marrow transplantation prevents the development
of PAH in patients with severe scleroderma
back to
calendarPresentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 15
participants after the webinar.
Date // 30 march 2022
NOTE: All times indicated are Greenwich mean Time (GMT)
aging and pulmonary hypertension:
an endemic at the horizon?
Presentations:
• Age-dependent prevalence of PH in the general population
• Senescence mechanisms and pulmonary vascular aging
• Metabolic syndrome and obesity leads to age-related PH
• Genetics and epigenetics in age-related PH
• Best abstract
• Best abstract
back to
calendarPresentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 16
participants after the webinar.
Date // 27 april 2022
NOTE: All times indicated are Greenwich mean Time (GMT)
The association between cancer and Ph:
a tale of two diseases
Presentations:
• Cancer induced PH: Embolism as a major inducer
• Cancer induced PH: Microenvironmental cancer niche as a major inducer
• Cancer therapies induced PH
• Cancer related signalling mechanisms underlying PH development
• Best abstract
• Best abstract
back to
calendarPresentations
If not all questions can be answered on the day,
all comments will be published and circulated to all
Webinar 17
participants after the webinar.
Date // 25 may 2022
NOTE: All times indicated are Greenwich mean Time (GMT)
Paediatric Ph
Presentations:
• Genetics of pulmonary arterial hypertension: What we can learn by
studying children with and without congenital heart disease
• Therapeutic options in advanced PVD: Potts shunt versus lung
transplantation
• Stem cells and regenerative medicine for neonatal lung disease:
Implications for COPD
• Assessment of operability in patients with congenital heart disease
and PAH: Fallacies and pitfalls
• Best abstract
• Best abstract
back to
calendarStep into the PVri
Digital Clinic...
...and claim CME credits.
PVRI
Pulmonary Vascular
Research Institute
www.pvrinstitute.org
The PVRI is a Registered Charity in the UK, No: 1127115.
Disclaimer: This programme and its contents are correct at the time of printing.You can also read
